Metoclopramide and unintended weight gain

International Journal of Eating Disorders

Volumn 34, Issue 2, 2003, Pages 265-268

  Sansone, Randy A ^a,c   Sansone, Lori A ^b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b Private Practice (Family Medicine)   (United States)

^c Sycamore Primary Care Center   (United States)

Author keywords

Anorexia nervosa; Gastric emptying; Metoclopramide; Weight gain

Indexed keywords

ALENDRONIC ACID; CITALOPRAM; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS NORGESTIMATE; GABAPENTIN; MACROGOL; MACROGOL 3350; METOCLOPRAMIDE; NORGESTIMATE; PROMETHAZINE;

ADULT; ANOREXIA NERVOSA; ARTICLE; BODY WEIGHT; CASE REPORT; DISEASE COURSE; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; HUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RISK BENEFIT ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH EMPTYING; WEIGHT; WEIGHT GAIN;

ADULT; ANOREXIA NERVOSA; ANTIEMETICS; BODY CONSTITUTION; BODY IMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; GASTRIC EMPTYING; GASTROPARESIS; HUMANS; METOCLOPRAMIDE; PRIMARY HEALTH CARE; WEIGHT GAIN;

EID: 0042208254     PISSN: 02763478     EISSN: None     Source Type: Journal    
DOI: 10.1002/eat.10181     Document Type: Article

References (16)

1. Baptista, T. (1999). Body weight induced by antipsychotic drugs: Mechanisms and management. Acta Psychiatrica Scandinavica, 100, 3-16.
2. Baptista, T., Hernandez, L., & Hoebel, B.G. (1990). Systemic sulpiride increases dopamine metabolites in the lateral hypothalamus. Pharmacology, Biochemistry and Behavior, 37, 227-229.
3. Baptista, T., Parada, M., & Hernandez, L. (1987). Long term administration of some antipsychotic drugs increases body weight and feeding in rats: Are D2 dopamine receptors involved? Pharmacology, Biochemistry and Behavior, 27, 399-405.
4. Habbick, B.F., & Gerrard, J.W. (1984). Failure to thrive in the contented breast-fed baby. Canadian Medical Association Journal, 131, 765-768.
5. Halmi, K.A. (1983). Behavior and drug therapy for anorexia nervosa. Behavioral Medicine Update, 4, 13-15.
6. Lazzara, R.R., Stoudemire, A., Manning, D., & Prewitt, K.C. (1986). Metoclopramide-induced tardive dyskinesia: A case report. General Hospital Psychiatry, 8, 107-109.
7. Leach, A.M. (1995). The psychopharmacotherapy of eating disorders. Psychiatric Annals, 25, 628-633.
8. Leibowitz, S.F., & Alexander, J.T. (1998). Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biological Psychiatry, 44, 851-864.
9. McClain, C.J., Humphries, L.L., Hill, K.K., & Nickl, N.J. (1993). Gastrointestinal and nutritional aspects of eating disorders. Journal of the American College of Nutrition, 12, 466-474.
10. Poortinga, E., Rosenthal, D., & Bagri, S. (2001). Metoclopramide-induced akathisia during the second trimester of a 37-year-old woman's first pregnancy. Psychosomatics, 42, 153-156.
11. Pryor, T., McGilley, B., & Roach, N.E. (1990). Psychopharmacology and eating disorders: Dawning of a new age. Psychiatric Annals, 20, 711-722.
12. Robinson, D., Omar, S.J., Dangel, C., Fenn, H., & Tinklengerg, J. (1994). Metoclopramide-induced extra pyramidal symptoms in a diabetic patient. Journal of the American Geriatrics Society, 42, 1307-1308.
13. Rockwell, W.K. (1986). Pharmacological approaches to the treatment of eating disorders. New Directions for Mental Health Services, 31, 61-69.
14. Saleh, J.W., & Lebwohl, P. (1980). Metoclopramide-induced gastric emptying in patients with anorexia nervosa. American Journal of Gastroenterology, 74, 127-132.
15. Sankaran, K., Yeboah, E., Bingham, W.T., & Ninan, A. (1982). Use of metoclopramide in preterm infants. Developmental Pharmacology and Therapeutics, 5, 114-119.
16. Walsh, B.T., & Devlin, M.J. (1992). The pharmacologic treatment of eating disorders. Psychiatric Clinics of North America, 15, 149-160.